Promoted Content Promoted Content

X

Digital content for NLS Pharmaceutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
NLS Pharmaceutics
Switzerland Flag
Country
Country
Switzerland
Address
Address
The Circle 6 | P.O. Box CH - 8058 Zurich
Telephone
Telephone
+41 44 512 21 50
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.accesswire.com/viewarticle.aspx?id=752824&lang=en

ACCESSWIRE
04 May 2023

https://www.clinicaltrialsarena.com/news/fda-nls-narcolepsy-phase-iii/

CLINICAL TRIALS ARENA
03 May 2023

https://www.accesswire.com/viewarticle.aspx?id=752432&lang=en

BUSINESSWIRE
02 May 2023

https://www.accesswire.com/viewarticle.aspx?id=751094&lang=en

ACCESSWIRE
25 Apr 2023

https://www.accesswire.com/viewarticle.aspx?id=745926&lang=en

ACCESSWIRE
27 Mar 2023

https://www.accesswire.com/viewarticle.aspx?id=741403&lang=en

ACCESSWIRE
01 Mar 2023

https://www.accesswire.com/737215/NLS-Pharmaceutics-Announces-Completion-of-Open-Label-Extension-Study-with-Quilience-Mazindol-ER-for-the-Treatment-of-Narcolepsy

ACCESSWIRE
30 Jan 2023

https://www.accesswire.com/736677/NLS-Pharmaceutics-Regains-Compliance-with-Nasdaq-Stockholders-Equity-Requirement

ACCESSWIRE
26 Jan 2023

https://www.accesswire.com/736231/NLS-Pharmaceutics-Announces-New-In-Vitro-Data-Reconfirming-QuiliencesR-Mazindol-ER-Unique-Dual-Mechanism-of-Action-Involving-Significant-Orexin-2-Receptor-Activity

ACCESSWIRE
23 Jan 2023

https://www.accesswire.com/732543/NLS-Pharmaceutics-Announces-Israeli-Patent-Grant-Covering-Mazindol-for-Treatment-of-Attention-Deficit-Hyperactivity-Disorder-and-Other-Sleep-Disorders-Through-2037

ACCESSWIRE
20 Dec 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY